W. L. Gore & Associates will present an overview of innovations within its Cardiac Business Unit, with a focus on structural heart and interventional cardiology therapies. The discussion will highlight Gore’s CARDIOFORM Septal Occluder and CARDIOFORM ASD Occluder technologies, which are designed to provide minimally invasive treatment options for patients with atrial septal defects and patent foramen ovale. Attendees will gain insight into the clinical challenges these devices address, the evolution of structural heart interventions, and the role of advanced biomaterials in improving patient outcomes. The presentation will also explore how collaboration between engineering, clinical science, and physicians continues to shape the future of cardiovascular care.

Sponsored by: W. L. Gore & Associates